
Keywords: MosquitoMate
![]() |
Independent evaluation of Wolbachia infected male mosquito releases for control of Aedes aegypti in Harris County, Texas, using a Bayesian abundance estimatorS. Lozano, K. Pritts, D. Duguma, C. Fredregill and R. Connelly, PLOS Neglected Tropical Diseases, 16:e0010907. 2022.![]() Among disease vectors, Aedes aegypti (L.) (Diptera: Culicidae) is one of the most insidious species in the world. The disease burden created by this species has dramatically increased in the past 50 years, and during this time countries have relied on pesticides for control and ... Keywords: engagement, genetic biocontrol, genetically engineered mosquitoes, history, MosquitoMate, Oxitec, policy, regulation |
![]() |
Independent evaluation of Wolbachia infected male mosquito releases for control of Aedes aegypti in Harris County, Texas, using a Bayesian abundance estimatorS. Lozano, K. Pritts, D. Duguma, C. Fredregill and R. Connelly, PLOS Neglected Tropical Diseases, 16:e0010907. 2022.![]() Author summary Aedes aegypti is one of the most important mosquito species because females can potentially carry pathogens that cause disease. These diseases have a tremendous impact worldwide making this species an important target of control. We evaluated a mosquito control ... Keywords: engagement, genetic biocontrol, genetically engineered mosquitoes, history, MosquitoMate, Oxitec, policy, regulation |
![]() |
Oxitec and MosquitoMate in the United States: lessons for the future of gene drive mosquito controlC. E. Schairer, J. Najera, A. A. James, O. S. Akbari and C. S. Bloss, Pathogens and Global Health, 2021.![]() ABSTRACTIn response to growing concerns regarding mosquito-borne diseases, scientists are developing novel systems of vector control. Early examples include Oxitec?s OX513A genetically-engineered mosquito and MosquitoMate?s Wolbachia-infected mosquito, and systems using ... Keywords: engagement, genetic biocontrol, genetically engineered mosquitoes, history, MosquitoMate, Oxitec, policy, regulation |

Contact
David O’Brochta
Foundation for the
National Institutes of Health
geneconvenevi@fnih.org
RSS